ARS Pharmaceuticals, Inc. (SPRY)
8.615
-0.12
(-1.43%)
USD |
NASDAQ |
May 11, 16:00
8.615
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals EPS Diluted (Quarterly) : -0.4172 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 0.2446 |
| Heron Therapeutics, Inc. | -0.0157 |
| Krystal Biotech, Inc. | 1.833 |
| Century Therapeutics, Inc. | -0.219 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.32M |
| Revenue (Quarterly) | 28.09M |
| Total Expenses (Quarterly) | 69.41M |
| Enterprise Value | 719.83M |
| Gross Profit Margin (Quarterly) | 78.09% |
| Profit Margin (Quarterly) | -147.1% |
| Earnings Yield | -20.17% |
| Normalized Earnings Yield | -20.17 |